Aratana Therapeutics to be acquired by Elanco Animal Health for $245 million
Aratana Therapeutics announced it has signed an agreement to be acquired by Elanco Animal Health, its global collaboration partner on GALLIPRANT® (grapiprant tablets). The deal is structured as a stock-for-stock transaction. April 26, 2019